Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
RLI Corp's leadership activity, highlighted by CEO Craig W. Kliethermes' purchase of company stock, signals internal confidence amidst various corporate actions. The company reported strong earnings per share in Q1 2026 but saw revenue miss projections. Despite this, RLI announced substantial dividend increases and authorized a significant repurcha…
The Chief Executive Officer of Twilio Inc., Khozema Shipchandler, executed a sale of company stock totaling approximately $5.97 million on May 26, 2026. This transaction involved the disposition of 32,158 shares of Class A Common Stock and was conducted under an established 10b5-1 trading plan following the exercise of employee options. Despite the…
Subir Dutt, Chief Sales Officer at Xometry Inc., executed a sale of company shares totaling $237,500. This transaction occurred as the stock trades near its 52-week high following significant gains. Separately, Xometry recently reported robust first quarter results and announced strategic appointments that underscore the company's involvement in th…
The recent activity by John T. Treace, Chief Executive Officer, Director, and a ten percent owner at Treace Medical Concepts, Inc. (NASDAQ:TMCI), indicates a substantial increase in his personal investment in the company. Over three transactions conducted between May 26 and May 28, 2026, Mr. Treace acquired a total of 115,520 shares of common stock…
George W. Cummings III, a director at Business First Bancshares, Inc., recently sold a significant block of company stock. This sale occurred against the backdrop of mixed first-quarter earnings for BFST, where the bank beat expectations on EPS but missed revenue targets. Despite this, Raymond James maintained an Outperform rating and price target,…
Sharon Spurlin, a director at Smart Sand, Inc. (NASDAQ:SND), recently sold 50,000 shares of common stock, totaling $246,500. This transaction occurs against the backdrop of significant stock price appreciation for SND. Separately, the company has reinforced its commitment to shareholder value by implementing a special cash dividend and adopting a n…
Watts Water Technologies Inc. (WTS) saw a reported insider transaction when Director Michael J. Dubose sold shares on May 28, 2026. This activity occurred against a backdrop of positive corporate developments, including the company's first-quarter 2026 earnings report, which surpassed analyst expectations for both EPS and revenue.
Charles Schwab Corp's leadership activity suggests internal confidence as CEO Richard A. Wurster acquired a substantial amount of common stock in May 2026. This buying spree occurs while the company is issuing significant senior notes and receiving positive revisions from major financial institutions, including price target increases and maintained…
COPT Defense Properties (NASDAQ:CDP) saw a director sell shares in late May. This transaction occurred against a backdrop of positive corporate news, including strong first quarter financial results and the declaration of an annualized dividend of $1.28 per share for the second quarter of 2026. The company's stock price is currently near its 52-wee…
Katayoun Motiey, Chief Legal Admin Sust Officer at Extreme Networks Inc. (EXTR), sold a total of 15,000 common shares valued at $397,500 on May 26, 2026. This sale was executed through a pre-arranged 10b5-1 trading plan adopted earlier in September 2025. These transactions occurred as EXTR stock trades near its annual high and has demonstrated sign…
Sanjit Biswas, the Chief Executive Officer of Samsara Inc. (NYSE:IOT), executed sales totaling approximately $8.07 million involving 263,900 shares of the company's Class A Common Stock between May 26 and May 28, 2026. These transactions were conducted through various trusts utilizing Rule 10b5-1 trading plans. Despite the executive sales, Samsara …
Cencora director D. Mark Durcan acquired a block of common stock, occurring while the company reported second-quarter financial results that missed expectations. Despite these earnings misses, Cencora announced key executive appointments and maintained its fiscal year guidance, leading to varied market reactions from analysts.
Ali-Jackson Kamil, a director at Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), executed a sale of common stock shares on May 26, 2026. This transaction occurred against a backdrop of positive corporate developments for Rigel, including significant first-quarter revenue increases and the securing of global licensing rights for a key oncology drug.
Chief Legal and Administrative Officer Todd M. Duchene sold a significant block of 10,000 shares of Core Scientific common stock, totaling $262,540, through a pre-arranged trading plan (Rule 10b5-1). This transaction occurs as the company's stock trades near its 52-week high. Separately, Core Scientific reported mixed Q1 2026 earnings and announced…
Cynthia DeLaney, a director at Applied Optoelectronics, Inc. (AAOI), sold shares totaling over $10.7 million on May 26, 2026. This sale occurred as the stock trades below the selling prices, amid investor concern regarding the company's high revenue valuation multiple and recent quarterly results.
A director at Strategy Inc executed a significant sale of the company's Class A Common Stock. This transaction occurred after the individual acquired an equal number of shares through the exercise of a Director Stock Option. Separately, Strategy Inc has been actively reducing its outstanding debt through large-scale repurchases and is continuing wi…
A director of First Keystone Corporation, Donald Matthew Bower, purchased shares on May 28, 2026. This activity occurred while the stock traded near $17.99 per share, slightly above the acquisition price of $18.00 per share. The company continues its dividend tradition, having maintained payments for 31 consecutive years and recently announced a qu…
Telos Corp's common stock saw a transaction involving the sale of shares by Director Derrick D. Dockery, totaling $38,240. This activity occurred against a backdrop of recently released Q1 2026 financial results that exceeded analyst expectations for both earnings per share and total revenue. Despite the strong operational performance reported in t…
Commerce.com's CFO & COO, Daniel Lentz, executed a sale of several thousand shares of the company's common stock in May 2026. Separately, Commerce.com announced significant strategic developments, including integrating PayPal’s Store Sync and adopting a stockholder rights plan following an unsolicited acquisition proposal from Rezolve Ai.
Ronald P. O’Hanley, Chairman and CEO of State Street Corp., executed a sale of company common stock totaling over $2.26 million. This transaction occurred against the backdrop of strong financial disclosures for Q1 2026, where adjusted earnings per share surpassed analyst expectations. Furthermore, several major financial institutions have reacted …
Jeffrey Heier, the Chief Scientific Officer of Ocular Therapeutix, Inc., executed a sale of company stock valued at approximately $24,747. This transaction was conducted through a pre-arranged automatic instruction to cover tax withholding related to vested restricted stock units. The news also highlights the company's recent Q1 2026 financial perf…
Twist Bioscience CEO, Emily M. Leproust, executed transactions involving the sale of company common stock totaling approximately $3.21 million over two days in late May 2026, utilizing a pre-arranged Rule 10b5-1 trading plan. These sales occurred as the stock was approaching its 52-week high and following recent earnings reports that highlighted st…
Penguin Solutions' Senior Vice President and Chief Legal Officer executed a sale of company shares. This activity occurred alongside recent operational updates, including the reporting of second-quarter fiscal 2026 results that beat revenue estimates. Analyst sentiment remains varied, with some firms maintaining positive ratings while others cite c…
Chief Development Officer Peter Kaiser sold shares of Ocular Therapeutix (OCUL) common stock, a transaction which was structured to cover tax withholding related to vested restricted units. This insider activity is viewed against the backdrop of recent operational challenges, including a first-quarter 2026 earnings and revenue miss, prompting close…
Jonathan Ilany, a director at Tiptree Inc., recently increased his personal stake in the company through an IRA purchase. This insider action takes place against the backdrop of Tiptree's planned sale of its subsidiary, The Fortegra Group, Inc., to DB Insurance Co., Ltd., which is expected to close next week.
